PRODUCT LITERATURE

Effectiveness of adjunctive clindamycin in β-lactam antibiotictreated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study

---

Clindamycin is strongly recommended as an adjunctive treatment to β-lactam antibiotics in patients with severe invasive group A β-haemolytic streptococcal (iGAS) infections. However, there is little evidence of a benefit in the use of clindamycin in humans, and its role, if any, in treating patients with invasive non-group A/B β-haemolytic streptococcal (iNABS) infections is unclear.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Clindamycin
Anerocid

Specific Detail Info

Lancet Infect Dis. 2021 May ; 21(5): 697–710

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment